FMP

FMP

Enter

ADAP - Adaptimmune Therapeutics plc

Valuation of Adaptimmune Therapeutics plc(ADAP), Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel

photo-url-https://financialmodelingprep.com/image-stock/ADAP.png

Adaptimmune Therapeutics plc

ADAP

NASDAQ

1.58 USD

-0.01 (-0.633%)

Valuation Date:

Mar 28, 2024 3:00 PM

Share Price on Valuation Date

$1.58

Stock Beta

2.389

Shares Outstanding

218541381

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep